Literature DB >> 21709609

Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease.

Jerome A Yesavage1, Art Noda, Beatriz Hernandez, Leah Friedman, Jauhtai J Cheng, Jared R Tinklenberg, Joachim Hallmayer, Ruth O'hara, Renaud David, Philippe Robert, Elizabeth Landsverk, Jamie M Zeitzer.   

Abstract

OBJECTIVES: One of the hypothesized causes of the breakdown in sleep-wake consolidation often occurring in individuals with Alzheimer disease (AD) is the dysfunction of the circadian clock. The goal of this study is to report indices of sleep-wake function collected from individuals with AD in relation to relevant polymorphisms in circadian clock-related genes.
DESIGN: One week of ad libitum ambulatory sleep data collection.
SETTING: At-home collection of sleep data and in-laboratory questionnaire. PARTICIPANTS: Two cohorts of AD participants. Cohort 1 (N = 124): individuals with probable AD recruited from the Stanford/Veterans Affairs, National Institute on Aging Alzheimer's Disease Core Center (N = 81), and the Memory Disorders Clinic at the University of Nice School of Medicine (N = 43). Cohort 2 (N = 176): individuals with probable AD derived from the Alzheimer's Disease Neuroimaging Initiative data set. MEASUREMENTS: Determination of sleep-wake state was obtained by wrist actigraphy data for 7 days in Cohort 1 and by the Neuropsychiatric Inventory questionnaire for Cohort 2. Both cohorts were genotyped by using an Illumina Beadstation (Illumina, San Diego, CA), and 122 circadian-related single-nucleotide polymorphisms (SNPs) were examined. In Cohort 1, an additional polymorphism (variable-number tandem repeat in per3) was also determined.
RESULTS: Adjusting for multiple tests, none of the candidate gene SNPs were significantly associated with the amount of wake time after sleep onset (WASO), a marker of sleep consolidation. Although the study was powered sufficiently to identify moderate-sized correlations, we found no relationships likely to be of clinical relevance.
CONCLUSIONS: It is unlikely that a relationship with a clinically meaningful correlation exists between the circadian rhythm-associated SNPs and WASO in individuals with AD.

Entities:  

Mesh:

Year:  2011        PMID: 21709609      PMCID: PMC3128424          DOI: 10.1097/JGP.0b013e31820d92b2

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  11 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  A CLOCK polymorphism associated with human diurnal preference.

Authors:  D Katzenberg; T Young; L Finn; L Lin; D P King; J S Takahashi; E Mignot
Journal:  Sleep       Date:  1998-09-15       Impact factor: 5.849

Review 3.  Reduced neuronal activity and reactivation in Alzheimer's disease.

Authors:  D F Swaab; P J Lucassen; A Salehi; E J Scherder; E J van Someren; R W Verwer
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

4.  Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome.

Authors:  T Ebisawa; M Uchiyama; N Kajimura; K Mishima; Y Kamei; M Katoh; T Watanabe; M Sekimoto; K Shibui; K Kim; Y Kudo; Y Ozeki; M Sugishita; R Toyoshima; Y Inoue; N Yamada; T Nagase; N Ozaki; O Ohara; N Ishida; M Okawa; K Takahashi; T Yamauchi
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

5.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 7.  PERIOD3, circadian phenotypes, and sleep homeostasis.

Authors:  Derk-Jan Dijk; Simon N Archer
Journal:  Sleep Med Rev       Date:  2009-08-29       Impact factor: 11.609

8.  A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients.

Authors:  J A Yesavage; L Friedman; H C Kraemer; A Noda; D Wicks; D L Bliwise; J Sheikh; J Tinklenberg; V Zarcone
Journal:  J Geriatr Psychiatry Neurol       Date:  1998       Impact factor: 2.680

9.  Sleep/wake cycle disturbance in Alzheimer's disease: how much is due to an inherent trait?

Authors:  Jerome A Yesavage; Joy L Taylor; Helena Kraemer; Art Noda; Leah Friedman; Jared R Tinklenberg
Journal:  Int Psychogeriatr       Date:  2002-03       Impact factor: 3.878

10.  Positional cloning of the mouse circadian clock gene.

Authors:  D P King; Y Zhao; A M Sangoram; L D Wilsbacher; M Tanaka; M P Antoch; T D Steeves; M H Vitaterna; J M Kornhauser; P L Lowrey; F W Turek; J S Takahashi
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

View more
  10 in total

Review 1.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

2.  Understanding Alzheimer's disease through the genetics of sleep.

Authors:  Ellen E Lee
Journal:  Int Psychogeriatr       Date:  2020-07       Impact factor: 3.878

Review 3.  Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review.

Authors:  B Guarnieri; M Musicco; P Caffarra; F Adorni; I Appollonio; D Arnaldi; A Bartoli; E Bonanni; U Bonuccelli; C Caltagirone; G Cerroni; L Concari; F I I Cosentino; S Fermi; R Ferri; G Gelosa; G Lombardi; S Mearelli; F Nobili; S Passero; R Perri; R Rocchi; P Sucapane; G Tognoni; S Zabberoni; S Sorbi
Journal:  Neurol Sci       Date:  2014-07-19       Impact factor: 3.307

Review 4.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

5.  CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease.

Authors:  J Thome; A N Coogan; A G Woods; C C Darie; F Häßler
Journal:  J Aging Res       Date:  2011-10-18

Review 6.  Circadian clocks and neurodegenerative diseases: time to aggregate?

Authors:  Michael H Hastings; Michel Goedert
Journal:  Curr Opin Neurobiol       Date:  2013-06-21       Impact factor: 6.627

Review 7.  Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.

Authors:  Li Shen; Paul M Thompson; Steven G Potkin; Lars Bertram; Lindsay A Farrer; Tatiana M Foroud; Robert C Green; Xiaolan Hu; Matthew J Huentelman; Sungeun Kim; John S K Kauwe; Qingqin Li; Enchi Liu; Fabio Macciardi; Jason H Moore; Leanne Munsie; Kwangsik Nho; Vijay K Ramanan; Shannon L Risacher; David J Stone; Shanker Swaminathan; Arthur W Toga; Michael W Weiner; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

Review 8.  Best practice in the management of behavioural and psychological symptoms of dementia.

Authors:  Olivier Pierre Tible; Florian Riese; Egemen Savaskan; Armin von Gunten
Journal:  Ther Adv Neurol Disord       Date:  2017-06-19       Impact factor: 6.570

Review 9.  Neurobiological Functions of the Period Circadian Clock 2 Gene, Per2.

Authors:  Mikyung Kim; June Bryan de la Peña; Jae Hoon Cheong; Hee Jin Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-07-01       Impact factor: 4.634

10.  Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment.

Authors:  Salvatore Mazzeo; Valentina Bessi; Silvia Bagnoli; Giulia Giacomucci; Juri Balestrini; Sonia Padiglioni; Giulia Tomaiuolo; Assunta Ingannato; Camilla Ferrari; Laura Bracco; Sandro Sorbi; Benedetta Nacmias
Journal:  Diagnostics (Basel)       Date:  2021-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.